Recombinant Chicken PLA2G1B

• Cat.No.: PLA2G1B-3919C
• Product Overview: Recombinant Chicken PLA2G1B full length or partial length protein was expressed.

Specification

• Source: Mammalian Cells
• Species: Chicken
• Tag: His
• Form: Liquid or lyophilized powder
• Endotoxin: < 1.0 eu per μg of the protein as determined by the LAL method.
• Purity: >80%
• Notes: This item requires custom production and lead time is between 5-9 weeks. We can custom produce according to your specifications.
• Storage: Store it at +4 oC for short term. For long term storage, store it at -20 oC～-80 oC.
• Storage Buffer: PBS buffer

Gene Information

• Gene Name: PLA2G1B phospholipase A2, group IB (pancreas) [ Gallus gallus (chicken) ]
• Official Symbol: PLA2G1B
• Gene ID: 416980
• Protein Refseq: NP_001138961
• UniProt ID: B8QN52

Reviews

03/12/2020

Its exceptional purity and stability make it an ideal choice for a wide range of applications, ensuring reliable and reproducible results.

10/16/2017

The PLA2G1B protein comes highly recommended for its exceptional performance in various research applications.

01/09/2016

Its unique characteristics contribute to obtaining clear and detailed structural information, allowing researchers to gain insights into protein interactions and conformational changes.

Q&As

How is PLA2G1B involved in cardiovascular diseases?

PLA2G1B is associated with atherosclerosis and other cardiovascular conditions due to its involvement in lipid metabolism and inflammation.

Are there potential neuroprotective effects of modulating PLA2G1B activity?

Modulating PLA2G1B activity could be explored for potential neuroprotective effects, given its involvement in processes related to neuroinflammation.

In what diseases is PLA2G1B dysregulation observed?

Dysregulation of PLA2G1B has been linked to inflammatory disorders, cardiovascular diseases, and certain cancers.

Can PLA2G1B be a therapeutic target for inflammatory conditions?

Yes, targeting PLA2G1B may be a potential therapeutic strategy for inflammatory diseases, as it plays a role in the production of inflammatory mediators.

Can PLA2G1B inhibitors be used for treating cancer?

Inhibiting PLA2G1B may be explored as a therapeutic approach in cancer treatment by disrupting lipid metabolism and inhibiting cancer cell proliferation.